Recent publications · Crossref
5 total works indexed
- Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
· 2017 · cited 1,947x
- Signaling from Rho to the Actin Cytoskeleton Through Protein Kinases ROCK and LIM-kinase
· 1999 · cited 1,344x
- Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)
· 2016 · cited 989x
- Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial
· 2022 · cited 731x
- Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
· 2017 · cited 646x
via Crossref · CC0
Wikidata facts
- Instance of
- human
- Gender
- male
- Citizenship
- Ryukyu Kingdom
- Father
- Shō Kei
- Languages spoken
- Ryukyuan
- Family
- Second Shō Dynasty
- Image
- King Sho Boku.jpg
Show 5 more facts
- date of birth
- 1739-05-03
- date of death
- 1794-02-19
- place of burial
- Tamaudun
- birth name
- 思五郎金
- Commons category
- Shō Boku
Sources (1)
via Wikidata · CC0
Available in 13 languages
via Wikidata sitelinks · CC0